Gladius Capital Management LP Sells 478 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Gladius Capital Management LP cut its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 27.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,235 shares of the specialty pharmaceutical company’s stock after selling 478 shares during the […]